Brief Alcohol Withdrawal Scale (BAWS)

The Brief Alcohol Withdrawal Scale (BAWS) is a 5‑item, rapid bedside tool to quantify alcohol withdrawal severity and guide symptom‑triggered treatment 1 [Level II evidence].

Tremor
No tremor0Not visible, but can be felt+1Moderate, with arms extended+2At rest, without arms extended+3
Diaphoresis
No Sweats0Mild, barely visible+1Beads of sweat+2Drenching sweats+3
Agitation
Alert and calm, (RASS = 0)0Restless, anxious, apprehensive, movements not aggressive, (RASS = 1)+1Agitated, frequent non-purposeful movement (RASS = 2)+2Very agitated or combative, violent (RASS = 3 or 4)+3
Confusion
Oriented to person, place, time0Disoriented to time or place, but not both+1Disoriented to time and place+2Disoriented to person+3
Hallucinations
None0Mild (vague report, reality testing intact)+1Moderate (more defined hallucinations)+2Severe (obviously responding to internal stimuli, poor reality testing)+3

Indications for Use

Used to assess alcohol withdrawal severity in hospitalized patients and guide symptom‑triggered benzodiazepine dosing. Indicated when rapid, simple, and more objective monitoring is needed, especially where CIWA‑Ar is too time‑consuming. Provides fast scoring (~65 seconds) with good sensitivity (79%) and specificity (88%) for DSM‑5 alcohol withdrawal at cut‑off ≥3 1. Helps reduce benzodiazepine exposure and maintain safety in inpatient protocols 2.

Insights & Cautions

Start with rapid, simple symptom scoring to guide benzodiazepine dosing. BAWS is quick (≈65 seconds) and reasonably accurate, with 79% sensitivity and 88% specificity at ≥3 for alcohol withdrawal in psychiatric patients 1 [Level II evidence]. Advantages: fast, objective, easier than CIWA-Ar. Cautions: limited validation outside low–moderate withdrawal; may underperform in severe/ICU settings; not a standalone predictor of severe withdrawal—combine with clinical judgment and risk tools (e.g., PAWSS).